Eric Lindquist
Chief Executive Officer at InnoSIGN BV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul van de Wiel | M | - |
InnoSIGN BV
 InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | - |
| Richard Buller | M | 74 | 5 years | |
| Allan W. May | M | - |
InnoSIGN BV
InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | 2 years |
| Igor Gorbatchevsky | M | - | 3 years | |
| Mark Mannebach | M | - | 2 years | |
| Bernhard Lampert | M | - | 3 years | |
| John R. MacDonald | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Arthur P. DeCillis | M | 68 | - | |
| Sheri Smith | F | - | - | |
| Marie DeGayner Kuker | F | - | - | |
| Jill Krause | F | - | 1 years | |
| Anke Pierik | M | - |
InnoSIGN BV
InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 9 | 75.00% |
| Netherlands | 3 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Lindquist
- Personal Network
